Reuters: Omicron Cases in the US Are Mostly in Vaccinated People

3
440

Most of the 43 COVID-19 cases caused by the Omicron variant identified in the United States so far were in people who were fully vaccinated. A third of them had received a booster dose, according to a U.S. report published on Friday, Reuters reported.

The U.S. Centers for Disease Control and Prevention (CDC) said that of the 43 cases attributed to the Omicron variant, 34 people had been fully vaccinated.

Fourteen of them had also received a booster, although five of those cases occurred less than 14 days after the additional shot before full protection kicks in.

Perhaps the vaccines don’t offer much protection against the new variant. So far, the variant is mild with few ending up hospitalized.  The WHO reported this week that no one has yet died from it. Some doctors in South Africa postulate that the virus might be getting weaker.

Among the Omicron cases, 25 were in people aged 18 to 39, and 14 had traveled internationally. Six people had previously been infected with the coronavirus.

Most of them only had mild symptoms such as coughing, congestion, and fatigue, the report said, and one person was hospitalized for two days. Other symptoms reported less frequently include nausea or vomiting, shortness of breath or difficulty breathing, diarrhea, and loss of taste or smell.

The CDC said that while many of the first reported Omicron cases appear to be mild, a lag exists between infection and more severe outcomes. Symptoms would also be expected to be milder in vaccinated persons and those with previous SARS-CoV-2 infection.

The Delta variant still accounts for more than 99% of all U.S. cases. But reports from South Africa show that the Omicron variant is very transmissible.

Even if most cases are mild, a highly transmissible variant could result in enough infections to overwhelm health systems, the CDC cautioned.

Laboratory studies released this week suggest that the Omicron variant will blunt the protective power of two doses of Pfizer (PFE.N) and BioNTech’s COVID-19 vaccine, although a third dose may restore that protection.

That sounds more like wishful thinking than a scientific analysis.

The U.S. has authorized COVID-19 vaccine booster doses for all Americans age 16 and older.

 

 

 

 


PowerInbox
0 0 votes
Article Rating
Subscribe
Notify of
guest

3 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments